COST INDEX
Tirz yr-one floor $139✓ audSema yr-one floor $119✓ audMicro sema 12-mo · reported $110on recFifty 410 prepay ~$133on recHims & Hers: brand + $149 fee (9/17) $298+on recHenry tirz M2M (9/17) $349on recMochi tirz all-in (9/17) $278on recAltRx promo door ~$89on recRemedy promo door $99→on recShedRx entry ~$199on recZepbound vial $299+shelfWegovy pen self-pay (9/17) $349shelf
VSCompare GLP-1 ProvidersYEAR-ONE MATH · LIVE-CHECKOUT AUDITSFind my program →

Provider file · insurance-first with brand pathways

Ro review (2026): the file, on record

Latest first-party read (September 17, 2026), from the open dataset. Ro Body (read September 17, 2026 at ro.co): tirzepatide — $448/mo all-in: $299 medication + $149/month membership (brand product; medication rises by dose); flags: membership stacked, rises with dose; dose policy rises with the dose; labs not advertised; pharmacies brand product; cancellation: the $39 start payment is refunded if not eligible. semaglutide — $298/mo all-in: $149 medication + $149/month membership (brand product; medication rises by dose); flags: membership stacked, rises with dose; dose policy rises with the dose; labs not advertised; pharmacies brand product; cancellation: the $39 start payment is refunded if not eligible. The file below records this site’s earlier, dated read; any figure it carries that the provider’s page no longer prints is kept as dated history and is not ranked. Dated pages, regenerated on every build: compounded tirzepatide online price · compounded semaglutide online price · NexLife true monthly cost · news ledger.

Billing model: Insurance-first with brand pathways. This file runs on published rates — no one has re-walked this checkout this cycle, and the page says so wherever a number appears. The audited benchmark for the whole field is the NexLife file; every figure below should be read against it.

What it costs, on record

Ro's play is coverage rather than cash price: prior-authorization navigation for brand Zepbound and Wegovy, hand-offs to LillyDirect ($349 [hist.; ~$299 as of 8/26] vials) and NovoCare ($499 Wegovy) when self-pay makes sense, and compounded options alongside. Cash pricing varies by pathway; the value is the navigation itself.

Fits if — and watch for

Fits if you have insurance worth fighting — one cleared prior authorization can beat every compounded price in the field. Watch what the navigation layer costs if the authorization fails, and which pathway your money actually lands in.

File status

Every figure above is an on-record published rate, filed in the open dataset with its source URL. An audit — a human re-walking the live checkout — converts this file's numbers to stamped figures or corrections; until then, under the site's iron rule, any audited competitor figure outranks these regardless of size. Compounded medications are not FDA-approved, and whether therapy fits you is a licensed clinician's call.

Open Ro ↗ partner link, sponsored tag attached · how the money works

Related: NexLife vs Ro · The insurance corner belt · Report an error in this file

SECOND VISIT?

Stop re-reading tabs — answer three questions and the field sorts itself. No email, no account.

Sort the field for me →